UK markets open in 2 hours 30 minutes
NIKKEI 225
37,940.13 +311.65 (+0.83%) HANG SENG
17,626.75 +342.21 (+1.98%) CRUDE OIL
83.89 +0.32 (+0.38%) GOLD FUTURES
2,347.50 +5.00 (+0.21%) DOW
38,085.80 -375.12 (-0.98%) Bitcoin GBP
51,504.88 +144.68 (+0.28%)
Annovis Bio, Inc. (ANVS)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 149.75M |
| Enterprise value | 144.00M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 19.68 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -3.20 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.59 |
| 52-week change 3 | -6.66% |
| S&P500 52-week change 3 | 21.08% |
| 52-week high 3 | 22.49 |
| 52-week low 3 | 5.42 |
| 50-day moving average 3 | 10.47 |
| 200-day moving average 3 | 10.68 |
Share statistics
| Avg vol (3-month) 3 | 226.71k |
| Avg vol (10-day) 3 | 260.91k |
| Shares outstanding 5 | 11.01M |
| Implied shares outstanding 6 | 11.01M |
| Float 8 | 8.14M |
| % held by insiders 1 | 24.59% |
| % held by institutions 1 | 11.46% |
| Shares short (15 Apr 2024) 4 | 1.45M |
| Short ratio (15 Apr 2024) 4 | 5.12 |
| Short % of float (15 Apr 2024) 4 | 17.40% |
| Short % of shares outstanding (15 Apr 2024) 4 | 13.19% |
| Shares short (prior month 15 Mar 2024) 4 | 1.35M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -121.77% |
| Return on equity (ttm) | -546.40% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | N/A |
| Net income avi to common (ttm) | -56.2M |
| Diluted EPS (ttm) | -6.23 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 5.75M |
| Total cash per share (mrq) | 0.52 |
| Total debt (mrq) | N/A |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 2.39 |
| Book value per share (mrq) | -0.74 |
Cash flow statement
| Operating cash flow (ttm) | -39.97M |
| Levered free cash flow (ttm) | -23.75M |
© 2024 Yahoo. All rights reserved.